Breast cancer is a heterogeneous disease. Differences in tumour phenotypes lead to varying aggressiveness and ability to respond to a given treatment. Nowadays, breast tumours are classified not only ...

Microarray technology could be used to tailor therapy according to the individual, and prevent breast cancer patients from having to undergo painful unsuccessful therapies. In a study published in the ...

Semi-quantitative protein analysis of HER2 and ER levels in human breast cancer reveals broad expression ranges within HER2+ and ER+ phenotypes No significant financial relationships to disclose. This ...

Although alterations in several specific genes have been implicated in breast cancer progression, greater understanding of the molecular basis of the disease may result from the evaluation of global ...

Chemotherapy and Survival Benefit in Elderly Patients With Advanced Non–Small-Cell Lung Cancer Identifying sources of variation in expression microarray data and the effect of variance in gene ...

Protein detection and quantification are daily occurrences both in research and diagnostic laboratories. Also, follow-ups of therapeutic treatments and prognoses have grown to rely more and more on ...

Microarrays have revolutionized cancer research over the past decade. In particular, microarrays provide for higher degrees of specificity and sensitivity while allowing research results to be ...

A groundbreaking study shows that breast cancer screening works better when it’s personalized. Instead of annual mammograms ...

Curious about how to detect and characterize tumor-derived biomarkers from liquid biopsy samples? Genomics-based methods now provide access to more molecular data than ever before, delivering cancer ...

Speaking of information access, consider the challenges of organizing content faced by microarray database designers. First, the amount of information on microarrays can be enormous. Second, each ...